Sexual Orientation and Gender Identity Data Collection in Cancer Care: A Nationwide Landscape Assessment Update
- PMID: 38768413
- PMCID: PMC11633324
- DOI: 10.1200/OP.23.00724
Sexual Orientation and Gender Identity Data Collection in Cancer Care: A Nationwide Landscape Assessment Update
Abstract
Purpose: Routine collection of sexual orientation (SO) and gender identity (GI; collectively SOGI) in cancer clinics advances cancer care equity.
Methods: In 2022, NCI Community Oncology Research Program (NCORP) practice groups were asked about routine collection of SOGI data in the electronic health record. The proportions of practice groups reporting collection of SO and/or GI data were calculated, and practice group characteristics were assessed for associations.
Results: Of 271 practice groups nationwide, 42% (n = 112) collect SO data, 58% (n = 157) collect GI data, and 35% (n = 96) collect both. In multivariate analyses, SO data collection was associated with practice groups having minority outreach staff (odds ratio [OR], 2.07 [95% CI, 1.12 to 3.81]; P = .02); GI data collection was associated with practice groups located in the Northeastern United States (OR, 2.08 [95% CI, 0.73 to 5.91]; P = .045), and those with a higher proportion of new patients who were White (OR, 1.02 [95% CI, 1.01 to 1.04]; P < .001). Practice groups in the South were least likely to collect SOGI data (OR, 0.49 [95% CI, 0.26 to 0.94]; P = .004). There were no statistically significant differences in SO and/or GI collection on the basis of the practice group's proportion of Medicaid/Medicare patients, number of new patients with cancer per year, or practice ownership.
Conclusion: Slightly over one third of NCORP practice groups report routinely collecting SOGI data. There are regional differences in data collection, underscoring the need to craft targeted, region-specific interventions focused on boosting the capture and recording of SOGI data in an affirming manner.
Conflict of interest statement
None of the authors has conflicts of interest directly related to the sponsorship of this study.
Comment in
-
Advancing Equity in Cancer Care: The Critical Role of Sexual Orientation and Gender Identity Data Collection.JCO Oncol Pract. 2024 Sep;20(9):1146-1148. doi: 10.1200/OP.24.00360. Epub 2024 Jun 10. JCO Oncol Pract. 2024. PMID: 38857459
Similar articles
-
Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups.Cancer. 2019 Apr 15;125(8):1313-1318. doi: 10.1002/cncr.31925. Epub 2018 Dec 18. Cancer. 2019. PMID: 30561776 Free PMC article.
-
Sexual Orientation and Gender Identity Data Collection in Oncology Practice: Findings of an ASCO Survey.JCO Oncol Pract. 2022 Aug;18(8):e1297-e1305. doi: 10.1200/OP.22.00084. Epub 2022 May 23. JCO Oncol Pract. 2022. PMID: 35605183 Free PMC article.
-
Assessment of Patient-Centered Approaches to Collect Sexual Orientation and Gender Identity Information in the Emergency Department: The EQUALITY Study.JAMA Netw Open. 2018 Dec 7;1(8):e186506. doi: 10.1001/jamanetworkopen.2018.6506. JAMA Netw Open. 2018. PMID: 30646332 Free PMC article.
-
Sexual Orientation and Gender Identity Reporting in Highly Cited Current Alcohol Research.LGBT Health. 2024 Jul;11(5):340-347. doi: 10.1089/lgbt.2023.0085. Epub 2023 Oct 20. LGBT Health. 2024. PMID: 37862224 Review.
-
A scoping review of the structuring of questions about sexual orientation and gender identity.J Community Psychol. 2023 Sep;51(7):2592-2617. doi: 10.1002/jcop.23048. Epub 2023 Apr 23. J Community Psychol. 2023. PMID: 37088990
Cited by
-
Patient Sexual Orientation and Gender Identity Information Practices in Oncology.JAMA Netw Open. 2025 Jun 2;8(6):e2516941. doi: 10.1001/jamanetworkopen.2025.16941. JAMA Netw Open. 2025. PMID: 40549385 Free PMC article.
-
Difference-Makers for Collecting Sexual Orientation and Gender Identity Data in Oncology Settings.Cancer Med. 2025 Mar;14(5):e70727. doi: 10.1002/cam4.70727. Cancer Med. 2025. PMID: 40047060 Free PMC article.
-
Gender and sex interactions are intrinsic components of cancer phenotypes.Nat Rev Cancer. 2025 Aug;25(8):634-648. doi: 10.1038/s41568-025-00829-4. Epub 2025 May 19. Nat Rev Cancer. 2025. PMID: 40389544 Review.
-
Cancer care for transgender and gender-diverse people: Practical, literature-driven recommendations from the Multinational Association of Supportive Care in Cancer.CA Cancer J Clin. 2025 Jan-Feb;75(1):68-81. doi: 10.3322/caac.21872. Epub 2024 Dec 9. CA Cancer J Clin. 2025. PMID: 39652385 Free PMC article. Review.
-
A Scoping Review Mapping Trans* and Gender Diverse People's Representation in Cancer Research.Cancer Med. 2025 Aug;14(15):e70774. doi: 10.1002/cam4.70774. Cancer Med. 2025. PMID: 40761093 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical